Announced
Completed
Synopsis
ArchiMed, a private equity firm, completed the acquisition of Cube Biotech, a biotechnology company, from Creathor Ventures, a private equity firm. Financial terms were not disclosed. “Partnering with ArchiMed will maximize Cube’s potential through better penetration of the US market, focused organic product and service expansion and the ability to leverage our knowledge and connections through acquisitions,” Barbara Maertens, Cube Co-Founder and Managing Director.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.